Dawson James Securities: Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering

SEATTLE, WA / ACCESSWIRE / April 11, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its prop...